Friday 27 November - Saturday 28 November
RACP, 1 O’Connell Street, Sydney NSW
In-depth training on the latest advancements in Breast Cancer Management for Advanced Trainees and Young Medical Oncologists.
The MOGA Breast Cancer Preceptorship aims to immerse advanced trainees and fellows in the evolving landscape of breast cancer treatment by providing an in-depth exploration of the pivotal clinical trials conducted over the past decade. Participants will delve into landmark studies, including those leading to the approval of CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted therapies, examining their design, methodologies, and outcomes.
The program will encourage critical analysis of these trials, assessing their impact on clinical practice, advancements in personalised medicine, and improvements in patient outcomes. By critiquing these studies, trainees will develop a nuanced understanding of evidence-based treatment strategies and the complexities involved in translating clinical research into routine care, ultimately enhancing their ability to contribute to future innovations in breast cancer therapy.
We hope you will join us for this important learning opportunity.
Learning Objectives
1. Deepen understanding of contemporary breast cancer clinical trials to enhance holistic and optimised treatment of patients with breast cancer.
2. Development of critical thinking through appraisal of research studies, assessing their validity, relevance, and applicability to clinical practice.
3. Develop appreciation of the role of multidisciplinary care in the management of patients with breast cancer.
The program will bring together Preceptees for 1.5 days of engaging presentations, expert-led lectures and interactive discussions. As part of the registration process, Preceptees will be invited to nominate a paper for presentation and will also be allocated clinical cases to present during the program. Presentations will be approximately 10 minutes, followed by group discussion and opportunities to explore the topic further.
Preceptors will play an important role in supporting their allocated Preceptees throughout the program, providing guidance and feedback to help them prepare and deliver their presentations.
Target Audience
Up to 35 early-career medical oncologists (within five years of receiving their Fellowship) and Advanced Trainees from across Australia will be invited to participate as Preceptees in the program.
Up to 12 early to mid-career medical oncologists with expertise and experience in breast cancer will be invited to join the program as Preceptors, providing guidance, support and mentorship to the Preceptees throughout the Preceptorship.
Preceptee registration
Applications are open to MOGA members. A refundable deposit of $150.00 + GST will be required at the time of registration to secure your place in the Preceptorship. The deposit will be refunded following full participation in the program.
Participants will receive complimentary registration, all course materials and catering throughout the program, including attendance at the Networking Reception.
Travel and accommodation support will also be available for eligible interstate and regional participants.
Program*
Day 1
8:00am Registration
8:30am Welcome
8:35am Session 1: Neoadjuvant HR+, TNBC, HER2+
9:50am Sponsor Presentation by Gilead
10:00am Morning Tea
10:15am Session 2: Case Presentations 1
11:30am Session 3: Adjuvant HR+, TNBC, HER2+
12:45pm Lunch
1:30pm Session 4: Case Presentations 2
2:45pm Afternoon Tea
3:00pm Sponsor Presentation by Novartis
3:10pm Session 5: Careers
3.40pm Session 6: Metastatic HR+, TNBC
5:00pm Day 1 Concludes
5:30pm - 6:30pm Networking Reception
Day 2
8:30am Welcome
8:35am Session 7: Metastatic HER2+, HER2 Low
9:50am Sponsor Presentation by Pfizer Oncology
10:00am Morning Tea
10:30am Session 8: Case Presentations 3
12:00pm Workshop Concludes
*Program subject to change
Join today and take advantage of members’ only benefits.
PRECEPTOR Expression of Interest (EOI)
Call for Expressions of Interest
Preceptors for Breast Cancer Preceptorship 2026
The Medical Oncology Group of Australia (MOGA) is seeking Expressions of Interest (EOI) from early to mid-career medical oncologists interested in volunteering as Preceptors for the 2026 Breast Cancer Preceptorship.
The Preceptorship will be held over 1.5 days on Friday 27 November – Saturday 28 November 2026 at RACP, 1 O’Connell Street, Sydney.
The program will be convened by A/Prof Connie Diakos and Dr Lina Pugliano and will bring together up to 35 Preceptees for an engaging program focused on professional learning, clinical case presentations and peer connection.
Preceptors will support 1–2 Preceptees with their clinical case presentations throughout the program, providing guidance, feedback and an opportunity to share their experience and expertise.
Registration, accommodation and travel support will be provided for Preceptors.
Medical oncologists with an interest and expertise in breast cancer from across Australia are warmly invited to submit an Expression of Interest.
As part of your EOI, please upload:
Your current CV, including a list of publications
Brief Supporting Statement
If you have any questions about the Preceptor role, please don’t hesitate to contact the MOGA Secretariat at moga@moga.org.au or Co-Convenor, A/Prof Connie Diakos at deputychair@moga.org.au.
Applications close Friday 11 September 2026
Program Sponsors
